Bruce Savage


BioQuest Consulting

 In total Bruce has raised >£13 M of investment capital for the companies he has co –founded.

A few highlights:-

1991               Founded Cytocell, a molecular diagnostics company; raised £8 M and ran the company which commercialised technology in-licensed from the University of Oxford. In 2014 Cytocell was acquired by Oxford Gene Technology

2002               Helped start up BioAnalab, a University of Oxford spin-out which provided analytical services to the pharma industry and was part time CEO until 2003. The company was acquired giving the investors an excellent return.

2004           Co-founder, and then CEO of CMP Therapeutics Ltd a company founded on Medical Research Council technology –  a novel compound for treatment of allergies and infectious diseases. Raised £5 M and took the compound from the lab through to completion of Phase II clinical trials. Stepped down in 2010.

2007            Working with H2O ventures to create 360 Genomics, a molecular diagnostics company, where he was Chairman. The company was acquired by a listed diagnostics company in 2013.

2010-13       CEO and then Chairman of Alchemy Pharmatech a company with a novel nasal drug delivery technology. He raised £450 k and helped take the product through to the start of trials.

In addition to these and other company activities Bruce is a director of a small investment fund and a Board Member of the European Diagnostics Clusters Alliance.